Screening of patients with idiopathic venous thromboembolism for paroxysmal nocturnal hemoglobinuria clones

Thromb Res. 2015 Jun;135(6):1107-9. doi: 10.1016/j.thromres.2015.04.006. Epub 2015 Apr 11.

Abstract

Paroxysmal nocturnal hemoglobinuria (PNH) is an uncommon disorder characterized by hemolysis, thrombosis and marrow failure. Whereas venous and arterial thrombosis is a very common symptom of the disease, the frequency of PNH clones in patients with unexplained venous thromboembolism, including deep vein thrombosis and pulmonary embolism, has not been studied. We conducted a cross sectional study evaluating the presence of PNH clones in patients with prevalent venous thromboembolism using a high sensitivity flow cytometry assay for erythrocytes and neutrophils. Among the 388 patients enrolled in the study one patient had a detectable PNH clone of 0.02% in the neutrophil population (0.26%; 95% CI 0.05 to 1.45) and no detectable erythrocyte clone. We conclude that the presence of PNH clones in patients with idiopathic venous thrombosis is rare. Screening for PNH clones among VTE patients might be better reserved for patients with signs of hemolysis.

Keywords: Paroxysmal nocturnal hemoglobinuria; Venous thromboembolism.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Cohort Studies
  • Cross-Sectional Studies
  • Diagnosis, Differential
  • Erythrocytes / cytology
  • Female
  • Flow Cytometry
  • Hemoglobinuria, Paroxysmal / diagnosis*
  • Hemolysis
  • Humans
  • Male
  • Middle Aged
  • Neutrophils / cytology
  • Prevalence
  • Venous Thromboembolism / diagnosis*